Cargando…

Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study

Studies using animal experiments have shown secondary neuronal degeneration in the thalamus after cerebral infarction. Neuroimaging studies in humans have revealed changes in imaging parameters in the thalamus, remote to the infarction. However, few studies have directly demonstrated neuronal change...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamauchi, Hiroshi, Kagawa, Shinya, Kusano, Kuninori, Ito, Miki, Okuyama, Chio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508960/
https://www.ncbi.nlm.nih.gov/pubmed/35862203
http://dx.doi.org/10.1161/STROKEAHA.122.038846
_version_ 1784797131318493184
author Yamauchi, Hiroshi
Kagawa, Shinya
Kusano, Kuninori
Ito, Miki
Okuyama, Chio
author_facet Yamauchi, Hiroshi
Kagawa, Shinya
Kusano, Kuninori
Ito, Miki
Okuyama, Chio
author_sort Yamauchi, Hiroshi
collection PubMed
description Studies using animal experiments have shown secondary neuronal degeneration in the thalamus after cerebral infarction. Neuroimaging studies in humans have revealed changes in imaging parameters in the thalamus, remote to the infarction. However, few studies have directly demonstrated neuronal changes in the thalamus in vivo. The purpose of this study was to determine whether secondary thalamic neuronal damage may manifest as a decrease in central benzodiazepine receptors in patients with cerebral infarction and internal carotid artery or middle cerebral artery disease. METHODS: We retrospectively analyzed the data of 140 patients with unilateral cerebral infarction ipsilateral to internal carotid artery or middle cerebral artery disease. All patients had quantitative measurements of (11)C-flumazenil binding potential (FMZ-BP), cerebral blood flow, and cerebral metabolic rate of oxygen using positron emission tomography in the chronic stage. Region of interest analysis was performed using NeuroFlexer—an automated region of interest analysis software using NEUROSTAT. RESULTS: In the thalamus ipsilateral to the infarcts, the values of FMZ-BP, cerebral blood flow, and cerebral metabolic rate of oxygen were significantly lower than those in the contralateral thalamus. Significant correlations were found between the ipsilateral-to-contralateral ratio of FMZ-BP and the ipsilateral-to-contralateral ratio of cerebral blood flow or cerebral metabolic rate of oxygen in the thalamus. Patients with corona radiata infarcts and striatocapsular infarcts had significantly decreased ipsilateral-to-contralateral FMZ-BP ratio in the thalamus compared with those without. The ipsilateral-to-contralateral ratio of FMZ-BP in the thalamus was significantly correlated with the ipsilateral-to-contralateral cerebral metabolic rate of oxygen ratio in the frontal cortex and showed a significant negative correlation with the number of perseverative errors on the Wisconsin Card Sorting Test. CONCLUSIONS: Secondary thalamic neuronal damage may manifest as a decrease in central benzodiazepine receptors in patients with cerebral infarction and internal carotid artery or middle cerebral artery disease, which may be associated with frontal lobe dysfunction.
format Online
Article
Text
id pubmed-9508960
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95089602022-09-26 Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study Yamauchi, Hiroshi Kagawa, Shinya Kusano, Kuninori Ito, Miki Okuyama, Chio Stroke Original Contributions Studies using animal experiments have shown secondary neuronal degeneration in the thalamus after cerebral infarction. Neuroimaging studies in humans have revealed changes in imaging parameters in the thalamus, remote to the infarction. However, few studies have directly demonstrated neuronal changes in the thalamus in vivo. The purpose of this study was to determine whether secondary thalamic neuronal damage may manifest as a decrease in central benzodiazepine receptors in patients with cerebral infarction and internal carotid artery or middle cerebral artery disease. METHODS: We retrospectively analyzed the data of 140 patients with unilateral cerebral infarction ipsilateral to internal carotid artery or middle cerebral artery disease. All patients had quantitative measurements of (11)C-flumazenil binding potential (FMZ-BP), cerebral blood flow, and cerebral metabolic rate of oxygen using positron emission tomography in the chronic stage. Region of interest analysis was performed using NeuroFlexer—an automated region of interest analysis software using NEUROSTAT. RESULTS: In the thalamus ipsilateral to the infarcts, the values of FMZ-BP, cerebral blood flow, and cerebral metabolic rate of oxygen were significantly lower than those in the contralateral thalamus. Significant correlations were found between the ipsilateral-to-contralateral ratio of FMZ-BP and the ipsilateral-to-contralateral ratio of cerebral blood flow or cerebral metabolic rate of oxygen in the thalamus. Patients with corona radiata infarcts and striatocapsular infarcts had significantly decreased ipsilateral-to-contralateral FMZ-BP ratio in the thalamus compared with those without. The ipsilateral-to-contralateral ratio of FMZ-BP in the thalamus was significantly correlated with the ipsilateral-to-contralateral cerebral metabolic rate of oxygen ratio in the frontal cortex and showed a significant negative correlation with the number of perseverative errors on the Wisconsin Card Sorting Test. CONCLUSIONS: Secondary thalamic neuronal damage may manifest as a decrease in central benzodiazepine receptors in patients with cerebral infarction and internal carotid artery or middle cerebral artery disease, which may be associated with frontal lobe dysfunction. Lippincott Williams & Wilkins 2022-07-06 2022-10 /pmc/articles/PMC9508960/ /pubmed/35862203 http://dx.doi.org/10.1161/STROKEAHA.122.038846 Text en © 2022 The Authors. https://creativecommons.org/licenses/by-nc-nd/4.0/Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Original Contributions
Yamauchi, Hiroshi
Kagawa, Shinya
Kusano, Kuninori
Ito, Miki
Okuyama, Chio
Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study
title Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study
title_full Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study
title_fullStr Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study
title_full_unstemmed Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study
title_short Neuronal Alterations in Secondary Thalamic Degeneration Due to Cerebral Infarction: A (11)C-Flumazenil Positron Emission Tomography Study
title_sort neuronal alterations in secondary thalamic degeneration due to cerebral infarction: a (11)c-flumazenil positron emission tomography study
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508960/
https://www.ncbi.nlm.nih.gov/pubmed/35862203
http://dx.doi.org/10.1161/STROKEAHA.122.038846
work_keys_str_mv AT yamauchihiroshi neuronalalterationsinsecondarythalamicdegenerationduetocerebralinfarctiona11cflumazenilpositronemissiontomographystudy
AT kagawashinya neuronalalterationsinsecondarythalamicdegenerationduetocerebralinfarctiona11cflumazenilpositronemissiontomographystudy
AT kusanokuninori neuronalalterationsinsecondarythalamicdegenerationduetocerebralinfarctiona11cflumazenilpositronemissiontomographystudy
AT itomiki neuronalalterationsinsecondarythalamicdegenerationduetocerebralinfarctiona11cflumazenilpositronemissiontomographystudy
AT okuyamachio neuronalalterationsinsecondarythalamicdegenerationduetocerebralinfarctiona11cflumazenilpositronemissiontomographystudy